Login Register Cart 0
Generic placeholder image

Current Chinese Science

Editor-in-Chief

ISSN (Print): 2210-2981
ISSN (Online): 2210-2914

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Case Report Section: Pharmacology

Recovery of a 91-year-old COVID-19 Patient with Medical and Psychological Support

Author(s): Dong Zhang, Chunrong Liu and Li Li*

Volume 1, Issue 2, 2021

Published on: 10 December, 2020

Page: [286 - 290] Pages: 5

DOI: 10.2174/2666001601999201210211231

Abstract

Background: Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is designated as a global pandemic. Elderly men with underlying medical conditions are more susceptible to SARS-CoV-2 infection and usually develop severe/ critical illness, therefore more attention we should be paid to them.

Objective: Describe methods that may help old patients with COVID-19 recover.

Methods: A case of a 91-year-old male COVID-19 patient in Haihe Hospital, Tianjin, China, has been reported here who survived after receiving supportive medical treatment and psychological assistance.

Results: In addition to medical interventions, psychological support may be needed to better treat COVID-19 patients, including the elderly.

Conclusion: Special care should be provided for elderly COVID-19 patients. Mutual understanding and support between patients and health-care workers are essential during this pandemic.

Keywords: COVID-19, SARS-CoV-2, elderly patient, psychological assistance, special care, family support.

« Previous
Graphical Abstract

[1]
Lythgoe, M.P.; Middleton, P. Ongoing clinical trials for the management of the COVID-19 pandemic. Trends Pharmacol. Sci., 2020, 41(6), 363-382.
[http://dx.doi.org/10.1016/j.tips.2020.03.006] [PMID: 32291112]
[2]
Yousefi, B.; Valizadeh, S.; Ghaffari, H.; Vahedi, A.; Karbalaei, M.; Eslami, M. A global treatments for coronaviruses including COVID-19. J. Cell. Physiol., 2020, 235(12), 9133-9142.
[http://dx.doi.org/10.1002/jcp.29785] [PMID: 32394467]
[3]
Wu, Z.; McGoogan, J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA, 2020, 323(13), 1239-1242.
[http://dx.doi.org/10.1001/jama.2020.2648] [PMID: 32091533]
[4]
Pinto, L.C.; Bertolucim, M.C. Type 2 diabetes as a major risk factor for COVID-19 severity: a meta-analysis. Arch. Endocrinol. Metab., 2020, 64(3), 199-200.
[http://dx.doi.org/10.20945/2359-3997000000256] [PMID: 32555985]
[5]
Yang, C.; Liu, F.; Liu, W.; Cao, G.; Liu, J.; Huang, S.; Zhu, M.; Tu, C.; Wang, J.; Xiong, B. Myocardial injury and risk factors for mortality in patients with COVID-19 pneumonia Int. J. Cardiol., 2020. [ePub ahead of Print]
[http://dx.doi.org/10.1016/j.ijcard.2020.09.048] [PMID: 32979425]
[6]
Damiani, I.; Corsini, A.; Bellosta, S. Potential statin drug interactions in elderly patients: a review. Expert Opin. Drug Metab. Toxicol, 2020. [ePub ahead of Print].
[http://dx.doi.org/10.1080/17425255.2020.1822324] [PMID: 32909838]
[7]
Du, R-H.; Liang, L-R.; Yang, C-Q.; Wang, W.; Cao, T-Z.; Li, M.; Guo, G-Y.; Du, J.; Zheng, C-L.; Zhu, Q.; Hu, M.; Li, X-Y.; Peng, P.; Shi, H-Z. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur. Respir. J., 2020, 55(5)
[http://dx.doi.org/10.1183/13993003.00524-2020] [PMID: 32269088]
[8]
Zhang, L.; Yu, J.; Zhou, Y.; Shen, M.; Sun, L. Becoming a faithful defender: Traditional Chinese medicine against coronavirus disease 2019 (COVID-19). Am. J. Chin. Med., 2020, 48(4), 763-777.
[http://dx.doi.org/10.1142/S0192415X2050038X] [PMID: 32349517]

Rights & Permissions Print Cite
Article Metrics
11
1
© 2024 Bentham Science Publishers | Privacy Policy